文献速递冠心病心力衰竭与心肌病血脂与心血管预防

2026 ACC科学声明:成人运动处方促进心血管健康

Exercise Prescriptions for Cardiovascular Health in Adults: 2026 ACC Scientific Statement: A Report of the American College of Cardiology.
PubMed 文献 · J Am Coll Cardiol · 2026-10-15

该科学声明由美国心脏病学会发布,为临床医生提供跨心血管健康与疾病谱的运动处方实用指导。声明回顾体力活动、运动训练和心肺适能改善心血管结局的证据,强调最不活跃者开始运动绝对获益最大,并总结不同训练类型、心脏康复模式及各类心血管疾病患者的个体化运动处方。

要点

  • 不活跃个体开始运动绝对获益最大,更高运动量和强度在临床允许范围内带来额外获益。
  • 大多数无症状个体无需常规运动前测试,运动测试用于评估安全性、指导强度和监测反应。
  • 运动应作为心血管预防和疾病管理的核心组成部分进行处方。

核心结论

  • 运动应作为心血管预防和疾病管理的核心组成部分进行处方。

研究设计与样本

  • 美国心脏病学会科学声明,基于现有证据综述提供运动处方实践指导。

主要发现

  • 不活跃个体开始运动绝对获益最大,更高运动量和强度在适当临床限制内带来额外获益。
  • 声明总结有氧、抗阻、平衡和柔韧性训练方法,并强调心脏康复及监督、家庭、混合和虚拟模式的作用。
  • 声明涵盖冠心病、外周动脉疾病、心力衰竭、心肌病、高血压、超重肥胖、成人先天性心脏病和老年患者的个体化运动处方。

关键数值与推荐

  • 大多数无症状个体无需常规运动前测试。
  • 运动测试可用于评估安全性、指导强度、建立基线适能和监测反应。
  • 可穿戴设备和数字工具可作为自我监测、目标设定和心脏康复延伸的辅助手段,需关注公平性、可及性和数字素养。

临床怎么用

  • 将体力活动咨询嵌入心血管诊疗,根据患者目标和功能能力定制运动处方。
  • 利用心脏康复及监督、家庭、混合和虚拟模式扩大运动干预覆盖。
  • 可穿戴设备和数字工具辅助自我监测与康复延伸。

局限性

  • 需扩大对长期依从性、临床结局、多样化人群和可扩展交付模式的研究。
  • 需改善临床医生培训。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Regular physical activity and structured exercise are foundational for cardiovascular prevention and treatment, yet exercise prescription remains inconsistently integrated into routine cardiovascular care. This American College of Cardiology scientific statement provides contemporary, practical guidance for clinicians on prescribing exercise across the spectrum of cardiovascular health and disease. The statement reviews evidence supporting physical activity, exercise training, and cardiorespiratory fitness as powerful determinants of cardiovascular outcomes, emphasizing that the greatest absolute benefits occur when inactive individuals begin moving and that additional benefits accrue with higher volumes and intensity, within appropriate clinical limits. It summarizes approaches to aerobic, resistance, balance, and flexibility training; highlights the role of cardiac rehabilitation and supervised, home-based, hybrid, and virtual models; and addresses individualized exercise prescription for patients with coronary artery disease, peripheral artery disease, heart failure, cardiomyopathies, hypertension, overweight and obesity, adult congenital heart disease, and older age. The statement also discusses when exercise testing is useful to assess safety, guide intensity, establish baseline fitness, and monitor responses, while recognizing that routine preparticipation testing is not required for most asymptomatic individuals. Wearable devices and digital tools are reviewed as adjuncts to self-monitoring, goal setting, and cardiac rehabilitation extension, with attention to equity, access, and digital literacy. Key implementation priorities include improving clinician training, embedding physical activity counseling into cardiovascular care, tailoring prescriptions to patient goals and functional capacity, and expanding research on long-term adherence, clinical outcomes, diverse populations, and scalable delivery models. Exercise should be prescribed as a core component of cardiovascular prevention and disease management.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Myers J, Beckie TM, Chastin S, et al. Exercise Prescriptions for Cardiovascular Health in Adults: 2026 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. 2026. PMID: 42878712. doi:10.1016/j.jacc.2026.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。